Countries South Korea

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leadin...

 May 24, 2021 | News

'CUVIS-spine' acquired FDA (US) licensing.

'CUVIS-spine' is available in all countries by acquiring the license from the FDA (US), Korea and Europe. 'CUVIS-spine' reduces surgery duration wi...

 May 22, 2021 | News

Cytiva launches sustainability plan - ‘Designing in sustainability’

Cytiva sets out a sustainability plan to positively affect people and the planet, which underpins business resilience in a fast-changing world Performan...

 May 13, 2021 | News

Navigo Proteins and MDimune Enter into a Research Collaboration

Navigo Proteins, a protein engineering biotech company generating scaffold protein-based affinity ligands, and MDimune, a biotech company developing an inn...

 May 11, 2021 | News

Cytiva strengthens commitment to foster talent pool in Korea

Cytiva is building its presence in the Korean market by expanding collaborations with top academic institutions. On April 27, we signed a memorandum of un...

 May 08, 2021 | News

Samsung Biologics and TG Therapeutics to enable global manufacturing of ublituximab

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization and TG Therapeutics (NASDAQ: TGTX), today...

 April 26, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close